Physician profile
Yeong Oh
NPI 1215953914
$1,621.21
in general payments reported to CMS, 2019-2025
23 companies · $18.93 in 2025
The $18.93 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,153 · 2020: $229 · 2021: $18.40 · 2022: $59.94 · 2023: $96.45 · 2024: $45.95 · 2025: $18.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $161.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $289.39 | 2019-2023 | Farxiga |
| Pfizer INC. | $166.05 | 2019-2022 | |
| Lilly USA, LLC | $164.25 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $149.34 | 2019 | |
| Gilead Sciences, INC. | $125.00 | 2019 | |
| Amarin Pharma, INC. | $124.11 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $107.97 | 2019-2025 | |
| Glaxosmithkline, LLC. | $89.53 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $68.23 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $56.56 | 2019 | |
| Abbott Laboratories | $45.95 | 2024 | Infinity |
| Amgen INC. | $45.83 | 2019-2020 | |
| Novo Nordisk INC | $31.86 | 2019-2020 | |
| Abbvie INC. | $22.79 | 2022 | |
| Dynavax Technologies Corporation | $19.79 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $18.40 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.34 | 2019 | |
| Horizon Therapeutics Plc | $15.28 | 2022 | |
| Arbor Pharmaceuticals, INC. | $14.82 | 2019 | |
| Radius Health, INC. | $13.89 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.03 | 2019 | |
| Allergan, INC. | $12.23 | 2020 | |
| Sanofi Pasteur INC. | $11.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yeong Oh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.